The ECI “Delivery of Nucleic Acid Therapeutics: Biology, Engineering and Development” conference will provide a forum for increasing our mechanistic understanding of the biological processes underpinning non-viral NAT delivery, including molecular and cellular biology, in vivo pharmacology and toxicology, rational optimization strategies, targeting, formulation, bioengineering and process development solutions for scale-up manufacturing, regulatory considerations and preclinical and clinical NAT programs.

The conference will bring together biologists, chemists, pharmacologists, biophysicists, drug developers, nanotechnologists, process engineers from academia and industry developing delivery strategies for the antisense, RNA interference, mRNA, Gene Therapy and Genome Editing, ex vivo and in vivo.

Event Link here.